Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT Plus vNKT for Pancreatic Cancer
NCT05783076Phase 2Unknown
- Sponsor
- Changhai Hospital
- Start
- Jun 2023
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in pancreatic ductal adenocarcinoma (PDAC), sponsored by Changhai Hospital. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05783076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05783076.